Harnessing Radioligand Therapy: Innovative Solutions for Advanced Prostate Cancer

This video is a recording of Prostate Cancer Foundation Canada's May 2024 Coast to Coast Support Group meeting held over Zoom.
This is a joint presentation by Dr. Anthony Helou and Dr. Marc-André Morin.
Anthony Helou is a leader in the pharmaceutical industry. He was involved in the introduction of important vaccines with Sanofi and Pfizer, including Pfizer-BioNTech's COVID-19 vaccine. He has a Doctor of Pharmacy degree from the University of Florida and is committed to advancing healthcare and pharmaceutical innovation.
Dr. Marc-André Morin is a doctor specializing in Nuclear Medicine, practicing at the Center Hospitalier de l’Université de Montréal and at the Center Hospitalier Universitaire de Québec. He also holds a bachelor’s degree in Physiotherapy from McGill University and a Doctorate in Medicine from Laval University. At the same time, he is completing a master's degree in university teaching of health sciences at the University of Montreal. He is also known as the first doctor in Quebec to have infused radioligand treatment for prostate cancer.
They are speaking here on Harnessing Radioligand Therappy: Innovative Solutions for Advanced Prostate Cancer.
For more information on Prostate Cancer Foundation Canada (formerly Prostate Cancer Foundation BC), a nonprofit proudly providing leadership and resources in prostate cancer support, awareness, and research since 1997, please visit: prostatecanada.ca
The views, information, and opinions expressed in this video are those of the individuals involved and do not necessarily reflect the official policy or position of Prostate Cancer Foundation Canada (PCFC) or its employees. PCFC is not responsible and does not verify for accuracy any of the information contained in the videos available for watching on this site. The primary purpose of these videos is to educate and inform, but these videos do not constitute, or replace, medical or other professional advice.